Paederus Induced Widespread Vesiculobullous Eruption
نویسندگان
چکیده
منابع مشابه
Non-Eczematous Vesiculobullous Skin Eruption after Stevens-Johnson Syndrome: Developed without Intravenous Immunoglobulin Therapy
Vol. 26, No. 6, 2014 789 Received November 14, 2013, Revised February 25, 2014, Accepted for publication March 14, 2014 Corresponding author: Hyun Jeong Park, Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 10 63-ro, Yeongdeungpo-gu, Seoul 150-713, Korea. Tel: 82-2-3779-1391, Fax: 82-2-783-7604, E-mail: hjpark@ catholic.ac.kr This i...
متن کاملHemorrhagic vesiculobullous eruption on the palms and the soles as presentation of dyshidrosiform bullous pemphigoid
BP: bullous pemphigoid DP: dyshidrosiform pemphigoid INTRODUCTION Dyshidrosiform bullous pemphigoid (DP) is an unusual localized variant of bullous pemphigoid (BP), first described by Levine et al in 1979. It presents with a persistent and recurrent vesicobullous eruption, sometimes hemorrhagic, localized to the soles and/or palms. Since the clinical manifestations of DP are similar to those of...
متن کاملPaederus Dermatitis
The problem of dermatitis is a common dermatological problem that can be seen worldwide. There are many kinds of dermatitis in clinical medicine. The paederus dermatitis is an interesting dermatitis. This kind of dermatitis is caused by poisonous insect[1]. The problematic causative insect that caused paederus dermatitis is called paederus insect[2]. This insect is a kind of bug that can be see...
متن کاملDocetaxel-induced photolichenoid eruption
A 58-year-old man presented with complaints of blackish discoloration of forearms and face of five months duration. The lesions occurred episodically after taking anti-cancer medications, each episode lasting for two weeks. Histopathology confirmed a lichenoid eruption. Photolichenoid eruption to docetaxel is a dermatological adverse effect not reported in literature earlier.
متن کاملBortezomib-induced skin eruption.
Bortezomib (Velcad) is a proteasome inhibitor recently developed and mainly used for the treatment of multiple myeloma. Bortezomib represents a novel class of drugs functioning as proteasome inhibitors. Skin complications of bortezomib treatment are very frequent but poorly characterized. We describe the case of a patient who developed erythematous and edematous plaques after treatment with bor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Case Reports
سال: 2012
ISSN: 2231-6809
DOI: 10.17659/01.2012.0035